Production (Stage)
Fractyl Health, Inc.
GUTS
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -59.46% | -22.50% | -17.80% | 45.12% | 1,380.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -59.46% | -22.50% | -17.80% | 45.12% | 1,380.00% |
| Cost of Revenue | -66.67% | -35.06% | -33.33% | 32.08% | 1,450.00% |
| Gross Profit | -47.27% | 0.00% | 12.50% | 68.97% | 1,275.00% |
| SG&A Expenses | 23.71% | 79.92% | 64.24% | 83.20% | 30.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.23% | 83.73% | 62.54% | 49.82% | 23.34% |
| Operating Income | -60.52% | -83.99% | -62.73% | -49.83% | -23.06% |
| Income Before Tax | -30.12% | 10.89% | 9.94% | 14.86% | -45.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.12% | 10.89% | 9.94% | 14.86% | -45.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.12% | 10.89% | 9.94% | 14.86% | -45.11% |
| EBIT | -60.52% | -83.99% | -62.73% | -49.83% | -23.06% |
| EBITDA | -59.69% | -83.80% | -62.91% | -50.18% | -23.59% |
| EPS Basic | 95.09% | 96.62% | 70.93% | 46.55% | -18.08% |
| Normalized Basic EPS | 91.90% | 94.03% | 59.54% | 27.66% | 8.28% |
| EPS Diluted | 95.09% | 96.62% | 70.93% | 46.55% | -18.08% |
| Normalized Diluted EPS | 91.90% | 94.03% | 59.54% | 27.66% | 8.28% |
| Average Basic Shares Outstanding | 436.53% | 1,990.82% | 1,442.83% | 894.16% | 345.33% |
| Average Diluted Shares Outstanding | 436.53% | 1,990.82% | 1,442.83% | 894.16% | 345.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |